Clinical practice and metabolic consequences of olanzapine use in schizophrenia: results from a national survey in Spain L.I. Muñoz-Manchado; M. Bernardo; J.M. Villagrán-Moreno; E. Fernández-Egea;

Hyperprolactinemia in drug-naïve first episode psychosis and its association with BDNF levels A Toll; D Bergé; L Martínez-Sadurní; A Trabsa; V Perez-Sola; A Mané;

Association between brain-derived neurotropic factor gene variant (rs6265; C¿>¿T) and schizophrenia, its psychopathology and intelligence S. Abbasian; S. Yoosefee; E. Shahsavand-Ananloo;